Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Management of Respiratory Failure

Initial Assessment and Management

  • The British Thoracic Society recommends assessing the severity of respiratory failure through clinical evaluation and arterial blood gas analysis 2, 3
  • The British Thoracic Society suggests identifying and treating the underlying cause of respiratory failure, such as infection, bronchospasm, or fluid overload 1, 4
  • Obtaining chest radiography is recommended to identify potential causes or complications, but treatment should not be delayed in severe cases 1
  • Documenting an individualized treatment plan at the start, including measures to be taken if initial therapy fails, is advised 1

Oxygen Therapy

  • The British Thoracic Society recommends administering controlled oxygen therapy targeting saturation of 88-92% for all causes of acute hypercapnic respiratory failure 1
  • Oxygen should be titrated carefully to improve hypoxemia without causing carbon dioxide retention or worsening acidosis, as recommended by the American Thoracic Society 5, 6
  • Continuous monitoring of oxygen saturation for at least 24 hours after commencing treatment is suggested 2, 3
  • Checking arterial blood gases after starting oxygen therapy is recommended to ensure adequate oxygenation without worsening hypercapnia, as advised by the American Thoracic Society 6

Pharmacological Management

  • For COPD exacerbations, the British Thoracic Society recommends administering nebulized bronchodilators, such as β-agonist or anticholinergic medications 4
  • Systemic corticosteroids, such as prednisolone, may be considered for patients with COPD exacerbations, as suggested by the British Thoracic Society 4
  • Antibiotics should be prescribed for patients with three cardinal symptoms, two cardinal symptoms if one is increased sputum purulence, or requirement for mechanical ventilation, as recommended by the American Thoracic Society 5
  • The recommended antibiotic duration is 5-7 days, as advised by the American Thoracic Society 5

Non-Invasive Ventilation (NIV)

  • The British Thoracic Society recommends initiating NIV when pH<7.35 and pCO2>6.5 kPa persist despite optimal medical therapy 1
  • NIV is preferred over invasive ventilation as the initial mode for treating acute respiratory failure in COPD exacerbations, with success rates of 80-85%, as reported by the American Thoracic Society 5, 6
  • Severe acidosis alone does not preclude a trial of NIV in an appropriate setting, as suggested by the British Thoracic Society 1
  • Measuring arterial blood gases after 1-2 hours of NIV and again after 4-6 hours if the earlier sample showed little improvement is recommended, as advised by the British Thoracic Society 2, 3

Invasive Mechanical Ventilation

  • The British Thoracic Society recommends considering invasive mechanical ventilation when NIV fails as initial therapy, patient has contraindications to NIV, or risk/benefit analysis favors better outcome with invasive ventilation 1, 5, 6
  • Factors favoring use of invasive ventilation include demonstrable remedial reason for current decline, first episode of respiratory failure, and acceptable quality of life or habitual level of activity, as suggested by the British Thoracic Society 7

Monitoring and Follow-up

  • Regular monitoring of arterial blood gases, vital signs, and clinical status is recommended, as advised by the British Thoracic Society 2, 3
  • Recording FEV1 before discharge and peak flow twice daily until clinically stable is suggested, as recommended by the British Thoracic Society 7
  • Checking arterial blood gases on air before discharge in patients who presented with hypercapnic respiratory failure is advised, as suggested by the British Thoracic Society 7
  • Planning early follow-up (<30 days) after discharge to review therapy and assess for complications is recommended, as advised by the American Thoracic Society 5